Austin James

2papers

2 Papers

CVAug 22, 2024
Sapiens: Foundation for Human Vision Models

Rawal Khirodkar, Timur Bagautdinov, Julieta Martinez et al.

We present Sapiens, a family of models for four fundamental human-centric vision tasks -- 2D pose estimation, body-part segmentation, depth estimation, and surface normal prediction. Our models natively support 1K high-resolution inference and are extremely easy to adapt for individual tasks by simply fine-tuning models pretrained on over 300 million in-the-wild human images. We observe that, given the same computational budget, self-supervised pretraining on a curated dataset of human images significantly boosts the performance for a diverse set of human-centric tasks. The resulting models exhibit remarkable generalization to in-the-wild data, even when labeled data is scarce or entirely synthetic. Our simple model design also brings scalability -- model performance across tasks improves as we scale the number of parameters from 0.3 to 2 billion. Sapiens consistently surpasses existing baselines across various human-centric benchmarks. We achieve significant improvements over the prior state-of-the-art on Humans-5K (pose) by 7.6 mAP, Humans-2K (part-seg) by 17.1 mIoU, Hi4D (depth) by 22.4% relative RMSE, and THuman2 (normal) by 53.5% relative angular error. Project page: https://about.meta.com/realitylabs/codecavatars/sapiens.

10.6CRApr 11
Artificial Pancreas Implantables -- How Healthcare Professionals May Deal With DIY Bio Cases

Austin James, Xavier-Lewis Palmer, Lucas Potter et al.

Automated insulin delivery (AID) and artificial pancreas systems increasingly serve as safety-critical cyber-physical technologies in clinical care, integrating sensors, algorithms, software, and insulin-delivery hardware to automate a life-sustaining therapy. While regulated commercial systems are supported by formal approval pathways, manufacturer governance, and post-market surveillance, clinicians are also encountering patients who rely on do-it-yourself (DIY) artificial pancreas systems that operate outside conventional regulatory and institutional control structures. This paper examines how routine clinical handling practices intersect with cyberbiosecurity risk across both regulated and DIY AID systems. When insulin delivery systems are fundamentally reconfigured into a bespoke AID system, with the patient-user becoming the primary threat vector by assuming manufacturer-level roles without mandated governance, the entire ecosystem of stakeholders is placed in legal and clinical uncertainty.